top of page
.png){kind=small}
Latest News
02/25/2025
Humanwell Pharmaceutical US Receives FDA Clearance to Advance Novel Analgesic RFUS-250 into Phase 1 Clinical Trials
Humanwell Pharmaceutical US, Inc. has received an official letter from the U.S. Food and Drug Administration (FDA), confirming the completion of the agency’s safety review for the clinical protocol submitted under the Investigational New Drug (IND) application for RFUS-250.
bottom of page